Prediction Markets Eye IonQ Micron Anduril as Potential Next US Government Stake Targets After Quantum Investments
US Jobless Claims Drop to Lowest Level Since MidMay Signaling Robust Labor Market
Top AI Infrastructure Stocks for 2026 Sector Analysis and Market Outlook
NASA Selects Blue Origin for Key Moon Base Mission Edging Out SpaceX
Treasury Yield Spread Narrows to OneYear Low as Traders Bet on Higher Rates Under New Fed Chair Warsh
Aluminum Price Surge Amid Iran Conflict Pressures Major US Companies
Spectral AI Inc MDAI Q1 2026 Earnings Missed Estimates as EPS Falls Short Shares Decline
PACCAR Q1 2026 Earnings EPS Slightly Misses Estimates Stock Holds Steady
DEI Q1 2026 Earnings EPS Surprise of 604 Highlights Operational Discipline
SVV Q1 2026 Earnings Missed EPS by a Narrow Margin Shares Edge Higher
CDLX Q1 2026 Earnings NarrowerThanExpected Loss Signals Operating Discipline
Datadog Q1 2026 Earnings EPS Surges Past Estimates as Strong Profitability Drives Stock Higher
Chart Industries GTLS Holds Steady Near Support Amid Industrial Sector Shifts
Antero Resources AR Slips 106 as Natural Gas Sector Faces Headwinds
Sleep Number Stock Hovers Near Support as Traders Eye Key Levels
Dragonfly Energy Holdings DFLI Gains 16 as Stock Holds Above Key Support Level
Auddia Inc AUUD Slides 688 as Sellers Test Key Support Near 142
SpaceX OpenAI Anthropic FirstDay Valuations Could Surpass Berkshire Hathaway Polymarket Traders Suggest
ACRE Q1 2026 Earnings Disappointing EPS Miss Amidst Challenging Commercial Real Estate Market
MediaAlpha MAX Edges Higher in Quiet Trading Holds Near Key Support
GALT Q1 2026 Earnings WiderThanExpected Loss as ClinicalStage Biotech Continues RD Spend
CIMN Q1 2026 Earnings EPS Beats Estimates Amid Steady Performance
ABCB Q1 2026 Earnings Ameris Bancorp Beats EPS Estimates with 257 Surprise
VINP Q1 2026 Earnings Earnings Miss Pressures Shares Amid Disappointing Quarter
GLAD Q1 2026 Earnings EPS Misses Estimates Shares Rise Despite 2057 Surprise
MCRB Q1 2026 Earnings EPS Misses Estimates Stock Declines 417
SVRA Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Continues Development